<code id='8165764595'></code><style id='8165764595'></style>
    • <acronym id='8165764595'></acronym>
      <center id='8165764595'><center id='8165764595'><tfoot id='8165764595'></tfoot></center><abbr id='8165764595'><dir id='8165764595'><tfoot id='8165764595'></tfoot><noframes id='8165764595'>

    • <optgroup id='8165764595'><strike id='8165764595'><sup id='8165764595'></sup></strike><code id='8165764595'></code></optgroup>
        1. <b id='8165764595'><label id='8165764595'><select id='8165764595'><dt id='8165764595'><span id='8165764595'></span></dt></select></label></b><u id='8165764595'></u>
          <i id='8165764595'><strike id='8165764595'><tt id='8165764595'><pre id='8165764595'></pre></tt></strike></i>

          Home / knowledge / knowledge

          knowledge


          knowledge

          author:entertainment    Page View:87
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In